Jens Standop

Jens Standop

Auto-generated profile, based on publicly available information

Jens Standop

Department of Surgery, University of Bonn Medical Center, Bonn, Germany

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
JSJens Standop
Jens Standop
TGTim Glowka
Tim Glowka
VSVolker Schmitz
Volker Schmitz
NSNico Schäfer
Nico Schäfer
MOMarcus Overhaus
Marcus Overhaus
JKJörg C. Kalff
Jörg C. Kalff

1 January 2015 in Clinica Chimica Acta
Verified
Journal Article
Open access
CKCatharina M. Korse
Catharina M. Korse
Stefan HoldenriederStefan Holdenrieder
Stefan Holdenrieder
XZXiu-Yi Zhi
Xiu-Yi Zhi
XZXiaotong Zhang
Xiaotong Zhang
LQLing Qiu
Ling Qiu
RMRafael Molina
Rafael Molina
We performed a multicenter evaluation of the Elecsys® progastrin-releasing peptide (ProGRP) immunoassay in Europe and China. The assay was evaluated at three European and two Chinese sites by imprecision, stability, method comparison and differentiation potential in lung cancer. Intermediate imprecision across five analyte concentrations ranged from 2.2% to 6.0% coefficient of variation. Good stability for plasma and serum samples was shown for various storage conditions. There was excellent correlation between the Elecsys® and ARCHITECT assays in plasma (slope 1.02, intercept -2.72pg/mL). The Elecsys® assay also showed good correlation between serum and plasma samples (slope 0.93, intercept 2.35pg/mL; correlation coefficient 0.97). ProGRP differentiated small-cell and non-small-cell lung cancer (NSCLC; area under the curve 0.90, 95% CI 0.87-0.93; 78.3% sensitivity, 95% specificity; at 84pg/mL), with no relevant effects of ethnicity, age, gender or smoking. Median ProGRP concentrations were low in benign diseases (38pg/mL), other malignancies (40pg/mL) or NSCLC (39pg/mL), except chronic kidney disease above stage 3 (>100pg/mL). Increased stability of the Elecsys® ProGRP assay in serum and plasma offers clear benefits over existing assays. This first evaluation of a ProGRP assay in China demonstrated comparable differentiation potential among different ethnicities.

1 October 2002
Verified
Journal Article
Closed access
WTWei-Gang Tong
Wei-Gang Tong
XDXian-Zhong Ding
Xian-Zhong Ding
RHRene Hennig
Rene Hennig
RWRichard C Witt
Richard C Witt
JSJens Standop
Jens Standop
TAThomas E Adrian
Thomas E Adrian

22 March 2005 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JSJens Standop
Jens Standop
MOMarcus Overhaus
Marcus Overhaus
NSNico Schaefer
Nico Schaefer
DDDorothee Decker
Dorothee Decker
MWMartin Wolff
Martin Wolff
ATAndreas Tuerler
Andreas Tuerler

1 March 2010 in Pancreas
Verified
Journal Article
Closed access
JSJens Standop
Jens Standop
TGTim Glowka
Tim Glowka
VSVolker Schmitz
Volker Schmitz
NSNico Schaefer
Nico Schaefer
AHAndreas Hirner
Andreas Hirner
JKJörg C. Kalff
Jörg C. Kalff
Pancreaticoduodenectomy is a demanding procedure even in selected patients but becomes formidable when performed in cases of emergency. This study analyzed our experience with urgent pancreatoduodenectomies; special emphases were put on the evaluation of diagnostic means and the validation of existing indications for performance of this procedure. Three hundred one patients who underwent pancreatoduodenectomy between 1989 and 2008 were identified from a pancreatic resection database and reviewed for emergency indications. Six patients (2%) underwent emergency pancreatoduodenectomy. Indications included endoscopy-related perforation, postoperative complications, and uncontrollable intraduodenal tumor bleeding. Length of stay and occurrence of nonsurgical complications were increased in emergency compared with elective pancreatoduodenectomies. Although increased, no significant differences were found regarding mortality and surgery-related complications. Indications for emergency pancreatoduodenectomies were based on clinical decisions rather than on radiologic diagnostics. Urgent pancreatic head resections may be considered as an option in selected patients if handling of local complications by interventional measures or limited surgery seems unsafe.

1 May 2014
Verified
Journal Article
Closed access
Stefan HoldenriederStefan Holdenrieder
Stefan Holdenrieder
YDYoganiranjana Dharuman
Yoganiranjana Dharuman
JSJens Standop
Jens Standop
NTNicolai Trimpop
Nicolai Trimpop
MHMarielle Herzog
Marielle Herzog
JMJake Micallef
Jake Micallef